Cardiovascular comorbidities in patients with psoriatic arthritis: a systematic review

A Jamnitski, D Symmons, MJL Peters… - Annals of the …, 2013 - ard.bmj.com
Objective Data regarding cardiovascular comorbidity and cardiovascular risk factors in
patients with psoriatic arthritis (PsA) are limited. To evaluate the cardiovascular risk profile, a …

[HTML][HTML] The potential harm of oxygen therapy in medical emergencies

AD Cornet, AJ Kooter, MJL Peters, YM Smulders - Critical Care, 2013 - Springer
In medical emergencies, supplemental oxygen is often administrated routinely. Most paramedics
and physicians believe that high concentrations of oxygen are life-saving [ 1 ]. Over the …

Does rheumatoid arthritis equal diabetes mellitus as an independent risk factor for cardiovascular disease? A prospective study

MJL Peters, VP van Halm, AE Voskuyl… - Arthritis Care & …, 2009 - Wiley Online Library
Objective Rheumatoid arthritis (RA) is associated with an increased risk of cardiovascular
disease (CVD), but longitudinal observations are limited and the precise magnitude is …

Associations between gut microbiota, faecal short-chain fatty acids, and blood pressure across ethnic groups: the HELIUS study

…, F Bäckhed, L Vogt, MJL Peters… - European heart …, 2020 - academic.oup.com
Aims Preliminary evidence from animal and human studies shows that gut microbiota
composition and levels of microbiota-derived metabolites, including short-chain fatty acids (SCFAs)…

Immunogenicity does not influence treatment with etanercept in patients with ankylosing spondylitis

…, LA Aarden, SO Stapel, MJL Peters… - Annals of the …, 2009 - ard.bmj.com
Background: Immunogenicity, specifically the onset of antibodies against tumour necrosis
factor (TNF) blocking agents, seems to play an important role in non-response to treatment …

Erythrocyte sedimentation rate, C‐reactive protein level, and serum amyloid A protein for patient selection and monitoring of anti–tumor necrosis factor treatment in …

…, IE van der Horst‐bruinsma, MJL Peters… - Arthritis Care & …, 2009 - Wiley Online Library
Objective To study the usefulness of erythrocyte sedimentation rate (ESR), C‐reactive
protein (CRP), and serum amyloid A (SAA) for response prediction and monitoring of anti–tumor …

Signs of accelerated preclinical atherosclerosis in patients with ankylosing spondylitis

MJL Peters, YVOM SMULDERS, E SERNE… - The Journal of …, 2010 - jrheum.org
Objective. Preliminary evidence suggests that ankylosing spondylitis (AS) is associated with
an increased cardiovascular (CV) risk. We investigated subclinical atherosclerosis and …

The effects of tumor necrosis factor inhibitors on cardiovascular risk in rheumatoid arthritis

M JL Peters, AM van Sijl, AE Voskuyl… - Current …, 2012 - ingentaconnect.com
There is abundant evidence that rheumatoid arthritis (RA), a chronic inflammatory disorder,
is associated with an increased risk for cardiovascular (CV) disease. While there may be …

The effect of TNF-alpha blocking therapy on lipid levels in rheumatoid arthritis: a meta-analysis

AM van Sijl, MJL Peters, DL Knol, RHC de Vet… - Seminars in arthritis and …, 2011 - Elsevier
OBJECTIVES: Changes in the lipid profile have been described in patients with rheumatoid
arthritis (RA) following therapy with tumor necrosis factor (TNF)-alpha blocking agents. …

Improvement of lipid profile is accompanied by atheroprotective alterations in high‐density lipoprotein composition upon tumor necrosis factor blockade: a prospective …

…, MK de Vries, JHM Levels, MJL Peters… - Arthritis & …, 2009 - Wiley Online Library
Objective Cardiovascular mortality is increased in ankylosing spondylitis (AS), and
inflammation plays an important role. Inflammation deteriorates the lipid profile and alters high‐…